Rare cancers

View All

Rare Cancer Market | Soft Tissue Sarcoma Market | Multiple Myeloma Market | Glioblastoma Multiforme Market | Cholangiocarcinoma Market | Synovial Sarcoma Market
Rare Cancer Market: A Global Crusade on what is a ‘less common cancer’?

Cancer is often challenging, however, diagnosis of rare cancer poses extra difficulties. Of all the diagnosed cancers, approximately 22% of the cases are rare cancers. According to the US National Cancer Institute, a cancer rare cancers as those with an incidence of fewer than 15 cases per 100 000 per year. Rare...

Find More


Alnylam’s Onpattro Receives First-Ever US FDA Approval for Treatment of the Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Adults US FDA approved Alnylam’s Onpattro (patisiran) lipid complex injection, a first-of-its-kind RNA interference (RNAi) therapeutic, for the treatment of the polyneurop...

Find More